For direct API integration and via third-party provider OpenRouter, MiniMax M2.7 maintains a cost-leading price point of 0.30 dollars per 1 million input tokens and 1.20 dollars per 1 million output ...
Over-the-top vitamin regimens have become bragging rights—and revenue streams—for the health-conscious and wellness-obsessed.
Nvidia unveiled a 5-layer AI platform at GTC 2026 spanning chips, agent runtimes, open models and factory blueprints. Here's ...
Over 95% of enterprises want to become their own AI and data platform within the next three years. This is the shift we’re ...
The applications and systems that software developers use on a daily basis are evolving as AI quickly becomes integrated into ...
PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced the appointment of Christopher Gibson, Ph.D., to PacBio’s Board of Directors. Dr. Gibson ...
Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.
22d
Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI-driven biological insight to meaningful patient outcomes; multiple ...
ARK Invest bought 1.25M shares of Recursion Pharmaceuticals for $4.33M ARK added 37,075 CRISPR Therapeutics shares worth $1.97M PagerDuty was the biggest sell at $3.89M for 566,650 shares ARK also cut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results